Welcome to our dedicated page for Orbsat SEC filings (Ticker: NXPLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NextPlat Corp (NXPLW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detail on topics such as governance decisions, shareholder votes, financial results announcements and listing matters related to the company’s common stock and warrants.
NextPlat’s recent Form 8-K filings describe events including the appointment of Rodney Barreto as Chairman of the Board and David Phipps as Chief Executive Officer following the passing of the prior Executive Chairman and CEO, as well as the announcement of quarterly financial results and the outcomes of its annual meeting of stockholders. One 8-K outlines shareholder voting results on the election of directors, ratification of the independent registered public accounting firm and advisory approval of executive compensation. Another 8-K discusses the company’s press release regarding financial results for a specific quarter.
Filings also document the company’s corporate information, such as its incorporation in Nevada and its listing on The Nasdaq Capital Market under the symbol NXPL, with related warrants referenced as NXPLW. In addition, NextPlat has publicly reported receiving an extension from Nasdaq to regain compliance with the minimum bid price requirement, a matter that may be further detailed in its regulatory communications.
On Stock Titan, these SEC filings are complemented by AI-powered summaries designed to explain the key points of each document in clear language. Users can review current reports, annual meeting voting results and other disclosures more efficiently, while still having access to the full original filings for deeper analysis.
NextPlat Corp is implementing a 1-for-10 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on April 13, 2026. Every 10 existing shares will be combined into 1 share, with par value staying at $0.0001.
The reverse split will reduce outstanding common shares from approximately 26.9 million to approximately 2.7 million, while authorized shares remain at 50 million. Stock options, warrants and equity plan reserves will be adjusted proportionately, increasing exercise prices and reducing underlying share amounts. No fractional shares will be issued; instead, holders will receive cash based on the Nasdaq closing price on the effective date.
NextPlat’s stock is expected to begin trading on a split-adjusted basis on April 13, 2026 under the symbol “NXPL” with a new CUSIP number. Historical per-share figures, including net loss per share, have been recast to reflect the new share count for 2025 and 2024.
NextPlat Corp reported full-year 2025 revenue of approximately $54.3 million, down 18% from about $66.1 million in 2024, as healthcare prescription volumes declined but e-commerce grew modestly. Healthcare revenue fell to $39.7 million from $52.3 million, driven by fewer prescriptions and lower 340B contract revenue, partly offset by higher reimbursement per script.
e-Commerce revenue increased to $14.6 million from $13.8 million on stronger airtime and hardware sales and favorable foreign exchange. Overall gross margin declined to about 20% from 26%, but total operating expenses were cut roughly in half to $19.9 million from $40.0 million, reflecting cost reductions and the absence of a prior-year impairment loss. Net loss attributable to common stockholders narrowed to approximately $11.7 million, or $0.44 per share, from $13.4 million, or $0.65 per share. The company ended 2025 with about $13.7 million in cash and roughly $15.0 million in working capital.
NextPlat Corp is a Nevada-based global e-commerce and healthcare services company operating two segments: e-Commerce Operations and Healthcare Operations. For the year ended December 31, 2025, approximately 27% of revenue came from e-Commerce and 73% from healthcare.
The e-Commerce segment sells satellite communications equipment and recurring airtime services through three proprietary websites, about 25 third-party storefronts and more than 10,000 product listings, reaching customers in over 165 countries. Amazon marketplaces represented approximately 31% of e-Commerce revenue in 2025.
The healthcare segment operates Progressive Care’s Pharmco pharmacies and ClearMetrX, providing retail and long-term care pharmacy services, 340B contract pharmacy services, data analytics and medication management in Florida and multiple other states. A Five Star EQuIPP performance score in 2025 highlights strong adherence metrics.
The company remains loss-making, with net losses of approximately $10.5 million in 2025 and $22.5 million in 2024 and an accumulated deficit of about $60.1 million as of December 31, 2025. As of March 27, 2026, there were 27,026,215 common shares outstanding, and non-affiliate equity was valued at about $11.2 million as of June 30, 2025.
NextPlat faces significant risks, including reliance on Amazon for e-commerce sales, dependence on McKesson for about 98% of pharmaceutical purchases in 2025, heavy use of the 340B Drug Pricing Program, and extensive healthcare and data privacy regulation. The company has received Nasdaq notices for failing to meet the $1.00 minimum bid price and pursued a 1-for-10 reverse stock split approved on March 27, 2026 to regain compliance and avoid potential delisting.
NextPlat Corp reported that on September 3, 2025 its Board appointed Rodney Barreto as Chairman and David Phipps as Chief Executive Officer, converting each from their interim roles following the May 2025 death of former Executive Chairman and CEO Charles M. Fernandez. Mr. Barreto had served as Interim Chairman and Mr. Phipps had served as Interim Chief Executive Officer since May.
The company states that Mr. Phipps’s existing employment agreement remains unchanged at the time of his permanent appointment. The company issued a press release on September 9, 2025 announcing the appointments and filed that release as Exhibit 99.1 to this Current Report.
NextPlat Corp furnished a press release announcing financial results for the quarter ended June 30, 2025. The press release is provided as Exhibit 99.1 and the filing also references a Cover Page Interactive Data File (Exhibit 104). The company states the information in the release is furnished and is not incorporated by reference into other filings and is not deemed to be "filed" for purposes of Section 18 of the Exchange Act or subject to liability under Sections 11 and 12(a)(2) of the Securities Act.
This report therefore notifies the market that quarter-end results were released but does not itself include those results within the body of the filing.